Ou Z - Search Results

1

Biweekly docetaxel-containing chemotherapy may be the optimal schedule.

Yang X, Cai Y, Zhao X, Wang Z, Hong X, Shen Z, Ou Z, Li J, Hu X. Yang X, et al. Among authors: ou z. Anticancer Drugs. 2008 Apr;19(4):421-6. doi: 10.1097/CAD.0b013e3282f7f52e. Anticancer Drugs. 2008. PMID: 18454052 Clinical Trial.

2

Suberoyl bis-hydroxamic acid enhances cytotoxicity induced by proteasome inhibitors in breast cancer cells.

Yang X, Shi Z, Zhang N, Ou Z, Fu S, Hu X, Shen Z. Yang X, et al. Among authors: ou z. Cancer Cell Int. 2014 Nov 12;14:107. doi: 10.1186/s12935-014-0107-7. eCollection 2014. Cancer Cell Int. 2014. PMID: 25729327 Free PMC article.

3

Chemokine decoy receptor d6 plays a negative role in human breast cancer.

Wu FY, Ou ZL, Feng LY, Luo JM, Wang LP, Shen ZZ, Shao ZM. Wu FY, et al. Mol Cancer Res. 2008 Aug;6(8):1276-88. doi: 10.1158/1541-7786.MCR-07-2108. Mol Cancer Res. 2008. PMID: 18708360

4

Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.

Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM. Feng LY, et al. Clin Cancer Res. 2009 May 1;15(9):2962-70. doi: 10.1158/1078-0432.CCR-08-2495. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383822

5

Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma.

Li HC, Cao DC, Liu Y, Hou YF, Wu J, Lu JS, Di GH, Liu G, Li FM, Ou ZL, Jie C, Shen ZZ, Shao ZM. Li HC, et al. Breast Cancer Res Treat. 2004 Nov;88(1):75-85. doi: 10.1007/s10549-004-1200-8. Breast Cancer Res Treat. 2004. PMID: 15538048

6

The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.

Li JY, Ou ZL, Yu SJ, Gu XL, Yang C, Chen AX, Di GH, Shen ZZ, Shao ZM. Li JY, et al. Breast Cancer Res Treat. 2012 Feb;131(3):837-48. doi: 10.1007/s10549-011-1502-6. Epub 2011 Apr 9. Breast Cancer Res Treat. 2012. PMID: 21479551

7

Expression of CXCL14 and its anticancer role in breast cancer.

Gu XL, Ou ZL, Lin FJ, Yang XL, Luo JM, Shen ZZ, Shao ZM. Gu XL, et al. Breast Cancer Res Treat. 2012 Oct;135(3):725-35. doi: 10.1007/s10549-012-2206-2. Epub 2012 Aug 22. Breast Cancer Res Treat. 2012. PMID: 22910931

8

The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.

Wang LP, Cao J, Zhang J, Wang BY, Hu XC, Shao ZM, Wang ZH, Ou ZL. Wang LP, et al. Med Oncol. 2015 Nov;32(11):254. doi: 10.1007/s12032-015-0696-6. Epub 2015 Oct 20. Med Oncol. 2015. PMID: 26487662

9

[Duffy antigen receptor for chemokines attenuates breast cancer growth and metastasis: an experiment with nude mice].

Wang J, Ou ZL, Hou YF, Luo JM, Chen Y, Zhou J, Shen ZZ, Ding J, Shao ZM. Wang J, et al. Zhonghua Yi Xue Za Zhi. 2005 Aug 3;85(29):2033-7. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16313795 Chinese.

10

Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.

Li DQ, Hou YF, Wu J, Chen Y, Lu JS, Di GH, Ou ZL, Shen ZZ, Ding J, Shao ZM. Li DQ, et al. Eur J Cancer. 2006 Dec;42(18):3274-86. doi: 10.1016/j.ejca.2006.07.008. Epub 2006 Sep 18. Eur J Cancer. 2006. PMID: 16979889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,197 results

Search Page

Filters